Read the Financial Press Critically

Recs

7

Disney Buys Marvel!

David Gardner called it. He’s up 1,334%! See what David’s recommending that you buy NEXT.

Stock Advisor

The financial press can be strange. I frequently run across interesting articles about various companies in my search for possible investments, so now and then I find useful lists of companies to think about. But sometimes, I still end up scratching my head.

For example, in its Jan. 5 issue, BusinessWeek magazine has an article about some stocks recommended by a handful of respected money managers. It listed five of them in a little table that had three columns: the company name and ticker, the reasons one might buy the stock, and the recent stock price.

I have to ask: What's with the stock price? It was as of Dec. 12, and by the time anyone read the article, it may well have changed considerably. But that's not my main beef. My main beef is that the price by itself is close to meaningless. It would be meaningful if one or more prices were under a dollar or two -- that would be a penny-stock red flag. But the prices were all well above $10 per share.

I shake my head because a stock's price shouldn't really matter much to us. If we want to invest in the company and we have $3,000 with which to do so, we can simply buy 100 shares if it's trading around $30 per share, or 175 shares if it's trading around $17 per share, or 36 shares if it's trading around $83 per share. Because remember -- a stock can be a screaming bargain at $250 per share and wildly overvalued at $2 per share. MasterCard (NYSE: MA), for example, was recently trading around $150 per share and is viewed by some as a better buy than Discover Financial Services (NYSE: DFS) at $10.

To be more useful, the table could have included some other metrics for each company, to help us know more about them. Their profit margins would have hinted at the brand and pricing power they enjoy. Their return on equity would have reflected their efficiency. Even their price-to-earnings ratios, if compared to their historic averages, could have suggested how undervalued they might be. So a more useful chart would look like this:

Stock

Dec. 31 Price

Current P/E

Return on Equity

Profit Margin

Coca-Cola (NYSE: KO)

45.27

17.7

27.8%

18.7%

Dow Chemical (NYSE: DOW)

15.09

5.5

14%

4.3%

Hewlett-Packard (NYSE: HPQ)

36.29

11.2

21.5%

7%

Schering-Plough (NYSE: SGP)

17.03

N/A

(16.3%)

(11.3%)

Tesco (OTC BB: TSCDY.PK)

15.85

13

19.5%

4.4%

Source: Yahoo! Finance and Capital IQ, a division of Standard and Poor's.

The good news is that at least readers got some investing ideas, and we can always research them further, seeking numbers that will tell us more. 

Closed for 15 months – opening 10 days only! Get notified ahead of time as our expert portfolio manager invests $1 MILLION in the best opportunities from across The Motley Fool’s premium investment services. This is the first open since August 2008, by invitation only. Enter email below.

Longtime Fool contributor Selena Maranjian owns shares of Coca-Cola. Coca-Cola and Discover Financial are Motley Fool Inside Value selections. Dow Chemical is a former Income Investor selection. Try our investing newsletters free for 30 days. The Motley Fool is Fools writing for Fools.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 803199, ~/Articles/ArticleHandler.aspx, 11/10/2009 7:30:29 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Health-Care Reform: A Tale of Two Chambers

Related Tickers

11/9/2009 4:01 PM
DFS $15.38 Up +0.85 +5.85%
Discover Financial… CAPS Rating: **
DOW $25.91 Up +1.11 +4.48%
The Dow Chemical C… CAPS Rating: ****
HPQ $49.99 Up +0.83 +1.69%
Hewlett-Packard Co… CAPS Rating: ***
KO $55.48 Up +0.99 +1.82%
The Coca-Cola Comp… CAPS Rating: ****
MA $242.19 Up +5.29 +2.23%
MasterCard, Inc. CAPS Rating: **
SGP $28.15 Down +0.00 +0.00%
Schering-Plough Co… CAPS Rating: ****

Community: Investing Wiki

Term Of The Hour

Biotechnology: Biotechnology uses biological processes to solve problems in such areas as health and medicine, agriculture and manufacturing.

Want to learn more or edit this definition?
Click here to read more!